Skip to main content
SpringerLink
Log in

Peroral Absorption of Octreotide in Pigs Formulated in Delivery Systems on the Basis of Superporous Hydrogel Polymers

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The aim of this study was to investigate the enhancement of peroral octreotide absorption using delivery systems based on superporous hydrogel (SPH) and SPH composite (SPHC) polymers.

Methods. Six female pigs (BW of 23.5 kg) were used in this study. SPH-based delivery systems were made of two components: 1) a conveyor system made of SPH and SPHC; 2) a core that contained octreotide. The core was inserted into the conveyor system (core inside, c.i.) or attached to the surface of the conveyor system (core outside, c.o.). Four different peroral formulations were investigated: c.i., c.o., core outside including trimethyl chitosan chloride (c.o.t.), and octreotide only in the absence of any polymer (o.o.). All formulations were placed in enteric-coated gelatin capsules (size 000) and administered perorally. Intravenous administration was used to determine bioavailability (F) values. Blood samples taken from the cannulated jugular vein were analyzed by radioimmunoassay.

Results. Peroral administration of 15 mg o.o. resulted in low F values of 1.0 ± 0.6% (mean ± SEM) whereas c.i. and c.o. administrations resulted in remarkably higher F values of 12.7 ± 3.6% and 8.7 ± 2.4%, respectively. By the addition of trimethyl chitosan chloride as an extra absorption enhancer to c.o.t., the highest bioavailability (16.1 ± 3.3%) was achieved.

Conclusions. These novel delivery systems based on SPH and SPHC polymers are able to increase the peroral bioavailability of octreotide by mechanical fixation and increasing the retention of the dosage form at the absorption site.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. J. A. Fix. Oral controlled release technology for peptides: status and future prospects. Pharm.Res. 13:1760-1764 (1996).

    Google Scholar 

  2. S. B. Zhou, X. M. Deng, and X. H. Li. Investigation on a novel core-coated microspheres proteins delivery system. J.Control.Release 75:27-36 (2001).

    Google Scholar 

  3. D. Ameye, J. Voorspoels, P. Foreman, J. Tsai, P. Richardson, S. Geresh, and J. P. Remon. Trypsin inhibition, calcium and zinc ion binding of starch-g-poly(acrylic acid) copolymers and starch/poly (acrylic acid) mixtures for peroral peptide drug delivery. J.Control.Release 75:357-364 (2001).

    Google Scholar 

  4. P. Langguth, V. Bohner, J. Heizmann, H. P. Merkle, S. Wolffram, G. L. Amidon, and S. Yamashita. The challenge of proteolytic enzymes in intestinal peptide delivery. J.Control.Release 46:39-57 (1997).

    Google Scholar 

  5. C. Damgé, J. Vonderscher, P. Marbach, and M. Pinget. Poly (alkyl cyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue. J.Pharm.Pharmacol. 49:949-954 (1997).

    Google Scholar 

  6. M. Thanou, J. C. Verhoef, J. H. M. Verheijden, and H. E. Junginger. Intestinal absorption of octreotide using trimethyl chitosan chloride: Studies in pigs. Pharm.Res. 18:823-828 (2001).

    Google Scholar 

  7. L. H. Ottesen, N. K. Aagaard, M. Kiszka-Kanowitz, M. Rehling, J. H. Henriksen, E. B. Pedersen, A. Flyvbjerg, and F. Bendtsen. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: A randomized, double-blind, controlled trial. Hepatology 34:471-477 (2001).

    Google Scholar 

  8. R. A. Harrigan, M. S. Nathan, and P. Beattie. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Ann.Emerg.Med. 38:68-78 (2001).

    Google Scholar 

  9. T. Takacs, F. Hajnal, J. Nemeth, J. Lonovics, and A. Pap. Stimulated gastrointestinal hormone release and gallbladder contraction during continuous jejunal feeding in patients with pancreatic pseudocyst is inhibited by octreotide. Int.J.Pancreatol. 28:215-220 (2000).

    Google Scholar 

  10. P. Schiedermaier, B. Goke, and T. Sauerbruch. Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in patients with TIPS. Am.J.Gastroenterol. 96:2218-2224 (2001).

    Google Scholar 

  11. J. Chen and K. Park. Synthesis and characterization of superporous hydrogel composites. J.Control.Release 65:73-82 (2000).

    Google Scholar 

  12. F. A. Dorkoosh, J. Brussee, J. C. Verhoef, G. Borchard, M. Rafiee-Tehrani, and H. E. Junginger. Preparation and NMR characterisation of superporous hydrogels (SPH) and SPH composites. Polymer 41:8213-8220 (2000).

    Google Scholar 

  13. F. A. Dorkoosh, J. C. Verhoef, G. Borchard, M. Rafiee-Tehrani, and H. E. Junginger. Development and characterization of a novel peroral peptide drug delivery system. J.Control.Release 71:307-318 (2001).

    Google Scholar 

  14. M. Thanou, J. C. Verhoef, P. Marbach, and H. E. Junginger. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo. J.Pharm.Sci. 89:951-957 (2000).

    Google Scholar 

  15. P. Marbach, M. Neufeld, and J. Pless. Clinical applications of somatostatin analogs. Adv.Exp.Med.Biol. 188:339-353 (1985).

    Google Scholar 

  16. M. Gibaldi and D. Perrier. Pharmacokinetics. In J. Swarbrick (ed.), Drugs and the Pharmaceutical Sciences, Marcel Dekker, New York, 1975 pp. 409-424.

    Google Scholar 

  17. G. A. Digenis, E. P. Sandefer, R. C. Page, W. J. Doll, T. B. Gold, and N. B. Darwazeh. Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture. Pharm.Res. 17:572-582 (2000).

    Google Scholar 

  18. A. F. Parr, E. P. Sandefer, P. Wissel, M. McCartney, C. McClain, U. Y. Ryo, and G. A. Digenis. Evaluation of the feasibility and use of a prototype remote drug delivery capsule (RDDC) for non-invasive regional drug absorption studies in the GI tract of man and beagle dog. Pharm.Res. 16:266-271 (1999).

    Google Scholar 

  19. F. A. Dorkoosh, G. Borchard, M. Rafiee-Tehrani, J. C. Verhoef, and H. E. Junginger. Evaluation of superporous hydrogel (SPH) and SPH composite in porcine intestine ex-vivo: Assessment of drug transport, morphology effect, and mechanical fixation to intestinal wall. Eur.J.Pharm.Biopharm. 53:161-166 (2002).

    Google Scholar 

  20. F. A. Dorkoosh, D. Setyaningsih, G. Borchard, M. Rafiee-Tehrani, J. C. Verhoef, and H. E. Junginger. Effects of superporous hydrogels on paracellular drug permeability and cytotoxicity studies in Caco-2 cell monolayers. Int.J.Pharm. 241:35-45 (2002).

    Google Scholar 

  21. S. S. Davis. Delivery systems for biopharmaceuticals. J.Pharm.Pharmacol. 44:186-190 (1992).

    Google Scholar 

  22. F. A. Dorkoosh, J. C. Verhoef, M. H. C. Ambagts, M. Rafiee-Tehrani, G. Borchard, and H. E. Junginger. Peroral delivery systems based on superporous hydrogel polymers: Release characteristics for the peptide drugs buserelin, octreotide and insulin. Eur.J.Pharm.Sci. 15:433-439 (2002).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Technology, Leiden/Amsterdam Center for Drug Research, Leiden University, P.O. Box 9502, 2300, RA Leiden, The Netherlands

    Farid A. Dorkoosh, J. Coos Verhoef, Morteza Rafiee-Tehrani, Gerrit Borchard & Hans E. Junginger

  2. Faculty of Veterinary Medicine, Utrecht University, P.O. Box 80163, 3508 TD, Utrecht, The Netherlands

    Jos H. M. Verheijden

Authors
  1. Farid A. Dorkoosh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Coos Verhoef
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jos H. M. Verheijden
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Morteza Rafiee-Tehrani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gerrit Borchard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hans E. Junginger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans E. Junginger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dorkoosh, F.A., Verhoef, J.C., Verheijden, J.H.M. et al. Peroral Absorption of Octreotide in Pigs Formulated in Delivery Systems on the Basis of Superporous Hydrogel Polymers. Pharm Res 19, 1532–1536 (2002). https://doi.org/10.1023/A:1020416918624

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020416918624

Search

Navigation